01 May 2025
// PRESS RELEASE
18 Mar 2025
// PRESS RELEASE
12 Feb 2025
// FDA
Strides Pharma Science: Pioneering IP-driven formulations for niche finished dosage forms.
About
CPhI North America CPhI North America
Industry Trade Show
Not Confirmed
20-22 May, 2025
euroPLX 88 LisboneuroPLX 88 Lisbon
Industry Trade Show
Attending
02-03 June, 2025
CPhI WW FrankfurtCPhI WW Frankfurt
Industry Trade Show
Booth # 9.1F6 & 9.1G41
28-30 October, 2025
CONTACT DETAILS
Events
Webinars & Exhibitions
CPhI North America CPhI North America
Industry Trade Show
Not Confirmed
20-22 May, 2025
euroPLX 88 LisboneuroPLX 88 Lisbon
Industry Trade Show
Attending
02-03 June, 2025
CPhI WW FrankfurtCPhI WW Frankfurt
Industry Trade Show
Booth # 9.1F6 & 9.1G41
28-30 October, 2025
CORPORATE CONTENT #SupplierSpotlight
https://www.pharmacompass.com/radio-compass-blog/chinese-fda-registered-generic-facilities-gain-steam-india-maintains-lead-with-396-facilities
01 May 2025
// PRESS RELEASE
https://strides.com/pdf/pressrelease/2025/StridesSEIntimation_30_Apr_2025.pdf
18 Mar 2025
// PRESS RELEASE
Chttps://strides.com/pdf/pressrelease/2025/StridesSEIntimation_signed_14_Mar_2025.pdf
12 Feb 2025
// FDA
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-february-12-2025-94329.pdf
31 Jan 2025
// PRESS RELEASE
https://strides.com/pdf/pressrelease/2025/newspaper_ad_31_jan_2025.pdf
23 Jan 2025
// PRESS RELEASE
https://strides.com/pdf/pressrelease/2025/StridesSEIntimation_22Jan_2025.pdf
22 Jan 2025
// PRESS RELEASE
https://strides.com/pdf/pressrelease/2025/StridesSEIntimation_22Jan_2025.pdf
Regulatory Info :
Registration Country : India
Dosage Form : Tablet
Brand Name :
Dosage Strength : 300MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Regulatory Info :
Registration Country : India
Dosage Form : Tablet
Brand Name :
Dosage Strength : 25MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Regulatory Info :
Registration Country : India
Dosage Form : Tablet
Brand Name :
Dosage Strength : 100MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Regulatory Info : RX
Registration Country : USA
Dosage Form : TABLET;ORAL
Brand Name : ACARBOSE
Dosage Strength : 25MG
Packaging :
Approval Date : 2011-07-27
Application Number : 90912
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Dosage Form : TABLET;ORAL
Brand Name : ACARBOSE
Dosage Strength : 100MG
Packaging :
Approval Date : 2011-07-27
Application Number : 90912
Regulatory Info : RX
Registration Country : USA
Regulatory Info :
Registration Country : India
Dosage Form : Tablet
Brand Name :
Dosage Strength : 50MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Regulatory Info : RX
Registration Country : USA
Dosage Form : TABLET;ORAL
Brand Name : ACARBOSE
Dosage Strength : 50MG
Packaging :
Approval Date : 2011-07-27
Application Number : 90912
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
ACETAMINOPHEN; BUTALBITAL; CAFFEINE
Dosage Form : TABLET;ORAL
Brand Name : BUTALBITAL, ACETAMINOPHEN...
Dosage Strength : 325MG;50MG;40MG
Packaging :
Approval Date : 2020-09-21
Application Number : 203647
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
ACETAMINOPHEN; BUTALBITAL; CAFFEINE
Dosage Form : TABLET;ORAL
Brand Name : BUTALBITAL, ACETAMINOPHEN...
Dosage Strength : 325MG;50MG;40MG
Packaging :
Approval Date : 2003-08-27
Application Number : 40511
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
ACETAMINOPHEN; BUTALBITAL; CAFFEINE; CODEINE PHOSPHATE
Dosage Form : CAPSULE;ORAL
Brand Name : BUTALBITAL, ACETAMINOPHEN...
Dosage Strength : 325MG;50MG;40MG;30MG
Packaging :
Approval Date : 2020-07-08
Application Number : 204649
Regulatory Info : RX
Registration Country : USA
Regulatory Info :
Registration Country : India
Dosage Form : Tablet
Brand Name :
Dosage Strength : 300MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Regulatory Info :
Registration Country : India
Dosage Form : Tablet
Brand Name :
Dosage Strength : 25MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Regulatory Info :
Registration Country : India
Dosage Form : Tablet
Brand Name :
Dosage Strength : 50MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Regulatory Info :
Registration Country : India
Dosage Form : Tablet
Brand Name :
Dosage Strength : 100MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Regulatory Info :
Registration Country : India
Dosage Form : Tablet
Brand Name :
Dosage Strength : 125MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Regulatory Info :
Registration Country : India
Dosage Form : Tablet
Brand Name :
Dosage Strength : 250MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Regulatory Info :
Registration Country : India
Dosage Form : Capsule
Brand Name :
Dosage Strength : 200MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Regulatory Info :
Registration Country : India
Dosage Form : Tablet
Brand Name :
Dosage Strength : 400MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Regulatory Info :
Registration Country : India
Dosage Form : Tablet
Brand Name :
Dosage Strength : 800MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Regulatory Info :
Registration Country : India
Dosage Form : Tablet
Brand Name :
Dosage Strength : 200MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Inspections and registrations
ABOUT THIS PAGE